Healthcare - Biotechnology - NASDAQ - US
$ 1.04
8.64 %
$ 45.7 M
Market Cap
-0.67
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
18.60%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Xilio Therapeutics, Inc.
XLO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart XLO
EBIT FORECAST
EBIT Forecast Chart XLO
NET INCOME FORECAST
Net Income Chart XLO